Brief: Elevai Labs says Nasdaq Grants Co Exception To Cure Bid Price Deficiency
13/11/2024 12:40
Nov 13 (Reuters) - Elevai Labs Inc ELAB.O :
* ELEVAI LABS INC: NASDAQ GRANTS ELEVAI LABS EXCEPTION TO
CURE BID
PRICE DEFICIENCY
* ELEVAI LABS INC: REQUIRED TO NOTIFY NASDAQ OF SIGNIFICANT
EVENTS
UNTIL JAN 9, 2025
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Announces DBA As NorthStrive Holdings Trademark License Agreement, & Website Update
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
Pmgc Holdings Rises As Unit Expands Rights To Ai: discovered obesity, heart disease drug program